Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TriReme CE marks Antares coronary stent system

This article was originally published in Clinica

Executive Summary

TriReme Medical has CE marked its Antares coronary stent system, which is designed for use at or near coronary bifurcations, for sale in Europe. Antares fits all classes of bifurcation lesions, irrespective of the size and angle of the side-branch, the Pleasanton, California firm says. It can be delivered and deployed in a single step while maintaining access to the side-branch, meaning the physician can deploy a second stent in the side-branch if necessary. TriReme claims it could be used in a quarter of the 2.2 million angioplasty procedures performed annually worldwide. The system is not yet approved in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041196

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel